Health

David Redfern: Pharma’s value proposition

February 10, 2011

Europe

David Redfern, CFO of GlaxoSmithKline, talks about how manifold challenges to the Pharma industry have led to a significant overhaul in the strategy of his organization.

Enjoy in-depth insights and expert analysis - subscribe to our Perspectives newsletter, delivered every week